Clinical trial
CIRculating Cell-free nUcLeic Acids in Cancer Therapy Monitoring -01
NCT05871593 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- CIRculating Cell-free nUcLeic Acids in Cancer Therapy Monitoring -01
- Lead sponsor
- University Hospital Tuebingen
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- October 31, 2023
- Completion date
- October 31, 2026
- Enrollment
- 200 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
next-generation-sequencing